问题 单项选择题

某开发区土地总面积为6km2,已完成“五通一平”。现拟出让该开发区一宗工业用地50年期的土地使用权,土地面积为1000m2。据调查,该开发区可供出让的土地面积约为4.5km2,平均征地费及相关税费为10万元/亩,完成1km2的土地开发需投入2亿元,开发期为2年,均匀投入全部土地投资回报率为15%,当地银行年贷款利率为6%,土地还原率为7%,50年期工业用地土地使用权市场价格与成本价格的比率为20%。
请就上述内容,回答下列各题:

土地投资利息为( )万元。

A.2.1

B.2.8

C.3.05

D.4.07

答案

参考答案:C

问答题 简答题
单项选择题

In 2010, a federal judge shook America’s biotech industry to its core. Companies had won patents for isolated DNA for decades—by 2005 some 20% of human genes were parented. But in March 2010 a judge ruled that genes were unpatentable. Executives were violently agitated. The Biotechnology Industry Organisation (BIO), a trade group, assured members that this was just a "preliminary step" in a longer battle.

On July 29th they were relieved, at least temporarily. A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed holb patents to two genes that help forecast a woman’s risk of breast cancer. The chief executive of Myriad, a company in Utah, said the ruling was a blessing to firms and patients alike.

But as companies continue their attempts at personalised medicine, the courts will remain rather busy. The Myriad case itself is probably not over Critics make three main arguments against gene patents: a gene is a product of nature, so it may not be patented; gene patents suppress innovation rather than reward it; and patents’ monopolies restrict access to genetic tests such as Myriad’s. A growing number seem to agree. Last year a federal task-force urged reform for patents related to genetic tests. In October the Department of Justice filed a brief in the Myriad case, arguing that an isolated DNA molecule "is no less a product of nature.., than are cotton fibres that have been separated from cotton seeds. "

Despite the appeals court’s decision, big questions remain unanswered. For example, it is unclear whether the sequencing of a whole genome violates the patents of individual genes within it. The case may yet reach the Supreme Court.

As the industry advances, however, other suits may have an even greater impact. Companies are unlikely to file many more patents for human DNA molecules I most are already patented or in the public domain. Firms are now studying how genes interact, looking for correlations that might be used to determine the causes of disease or predict a drug’s efficacy, companies are eager to win patents for ’connecting the dits’, explains Hans Sauer, a lawyer for the BIO.

Their success may be determined by a suit related to this issue, brought by the Mayo Clinic, which the Supreme Court will hear in its next term. The BIO recently held a convention which included seddions to coach lawyers on the shifting landscape for patents. Each meeting was packed.

By saying "Each meeting was packed" (Line 3, Para. 6) the author means that()

A. the supreme court was authoritative

B. the BIO was a powerful organization

C. gene patenting was a great concern

D. lawyers were keen to attend conventions